Indication
Keratitis
4 clinical trials
4 products
Clinical trial
An 8-week Phase I/II, Multicenter, Randomized, Double-masked, Vehicle Controlled Parallel Group Study to Evaluate the Safety and Efficacy of Two Doses of Recombinant Human Nerve Growth Factor in Patients With Stage 2 and 3 of NKStatus: Completed, Estimated PCD: 2015-04-01
Product
rhNGFProduct
PXL Platinum 330Clinical trial
Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal UlcersStatus: Recruiting, Estimated PCD: 2023-11-24
Clinical trial
Use of a New Rapid Multiplex PCR System for the Microbiological Diagnosis of Severe Infectious Keratitis: Impact on Therapeutic Management (ABCORFILM Study)Status: Recruiting, Estimated PCD: 2025-07-07
Product
PCR multiplexClinical trial
A Phase IV, Prospective, Open-label, Multicentre, Single Arm, 3-month Proof of Concept Study to Assess the Effect of IKERVIS® Eye Drops Administered Once Daily on the Quality of Vision in Dry Eye Disease (DED) Patients With Severe KeratitisStatus: Completed, Estimated PCD: 2018-07-11
Product
Ciclosporin